Key Findings

The study identifies several extended-spectrum beta-lactamases (ESBLs) in Canadian hospitals, including novel variants such as TEM-115, TEM-120, SHV-40, SHV-41, and SHV-42, highlighting the diversity and emergence of these resistance mechanisms in Escherichia coli and Klebsiella spp.